+1 (800) 297-5497 In-house regulatory specialists NDA available Houston, Texas · Since 2013
ICSDS/ Insights/ Market Entry
Market Entry

Entering the U.S. market: sequencing the compliance work

Most delays in U.S. entry are sequencing failures, not regulatory surprises. Mapping dependencies first keeps documentation off the critical path.

Companies that already sell successfully elsewhere often assume U.S. entry is a translation exercise. In practice the questions differ: chemical regulatory status, hazard communication, consumer labeling, and channel-specific expectations can all apply to the same product.

Establish what you already have

Existing Safety Data Sheets, labels, formulations, specifications, and transport documentation are assets. The first task is determining which of them support U.S. requirements as written, and which need work.

Identify the dependencies early

  • Chemical regulatory status may need to be settled before documentation is finalized
  • Hazard classification decisions drive both SDS and label content
  • Labeling requirements may vary by intended use and sales channel
  • Retailer onboarding often requests documentation before the launch date

The compliance work is rarely the long pole. Discovering it late is.

Sequence the work so nothing waits on nothing

A practical order is: assess status and documentation, resolve classification questions, prepare or revise the SDS, review labeling and artwork, then respond to channel-specific requests. Running these in parallel without confirming dependencies is what produces rework.

Information that accelerates scoping

Product type and intended use, the country where it is currently sold, existing SDS and label, formulation information where required, intended U.S. sales channels, and target launch timing.

Share
LinkedIn Email
Start a project

Bring the problem. We will help define the compliance path.

No long technical questionnaire. Give us the project context — we will ask for technical detail only where it matters.

NDA available before you share anything confidential.
Reviewed by in-house regulatory professionals.
Scope and timeline agreed before work begins.
+1 (800) 297-5497

Start the conversation

Step 1 of 2

Six fields. No technical detail yet.

What do you need help with? *
Step 2 is optional.